Clinical Studies

Mechanical Thrombectomy

APERIO® REVISAR (PMCF) APERIO® REVISAR (PMCF)

REcanalization of Distal cerebral Vessels In Acute Stroke using ApeRio® - REVISAR

PI:
Dr. Franziska Dorn, University Hospital Bonn, Germany
Sponsor: ACANDIS GmbH, Pforzheim, Germany
Device: APERIO® Thrombectomy Device/ APERIO® Hybrid Thrombectomy Device/ APERIO® Hybrid17 Thrombectomy Device
Clinical trials.gov identifier: NCT04479020
Study Type: Prospective, one-armed, open-label, multicentre, national
Objective:
The evaluation of the safety and efficacy of the APERIO® and APERIO® Hybrid(17) Thrombectomy Device in artery occlusions in the anterior and posterior circulation with a vessel diameter < 3 mm
(Est.) Enrolment: 130 patients
Status: Active, enroling

 

APERIO® HYBRID (PMCF) APERIO® HYBRID (PMCF)

APERIO® HYBRID Thrombectomy device for flow restoration in vessels of patients experiencing acute ischemic stroke  - HYBRID

PI:
Dr. Christian Mathys, Evangelisches Krankenhaus Oldenburg, Germany
Sponsor: ACANDIS GmbH, Pforzheim, Germany
Device: APERIO® Hybrid Thrombectomy Device/ APERIO® Hybrid17 Thrombectomy Device
Clinical trials.gov identifier: NCT04457479
Study Type: Prospective, one-armed, open-label, multicentre, national
Objective:
The investigation of potential residual risks associated with the use of the device and to update the clinical evaluation of the device in order to ensure the long-term safety and performance of the APERIO® Hybrid(17)  Thrombectomy Device after its placing on the market

(Est.) Enrolment: 430 patients
Status: Active, enroling